Revenue and Accounts Receivable (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Revenue From Each of the Company’s Customers

The following table summarizes net revenue from each of the Company’s customers, who individually represent at least 10% of total revenue.


	Three Months Ended March 31,
	2026		2025
Customer A	24	%	78	%
Customer B	23	%	14	%
Customer C	30	%	0	%

The following table summarizes accounts receivable concentrations for each of the Company’s customers, who individually represent at least 10% of gross total accounts receivable.


	March 31, 2026		December 31, 2025
Customer A	18	%	20	%
Customer B	31	%	23	%
Customer C	37	%	41	%

Schedule of Major Categories of Variable Consideration Deductions

A roll forward of the significant categories of Sales Allowances and the related accrual balances on the Condensed Consolidated Balance Sheet for the three months ended March 31, 2026 is as follows:


	Volume Incentive Rebates	Medicaid	Distribution Service Fees	Accrued Shelf- stock Liability	Accrued Returns Allowance	Chargebacks
Balance at December 31, 2025	86,001	12,418	5,780	2,255	18,291	4,304
Provisions related to sales recorded in the period	45,778	2,348	17,878	4,983	1,699	26,535
Credits/payments issued during the period	(86,193)	(735)	(15,549)	(2,175)	(924)	(19,389)
Effect of change in estimate	-	(3,187)	-	-	(5,796)	-
Balance at March 31, 2026	45,586	10,844	8,109	5,063	13,270	11,450